Page last updated: 2024-10-25

deferoxamine and Experimental Neoplasms

deferoxamine has been researched along with Experimental Neoplasms in 12 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"Cells from a rat hepatoma grown in culture were found to activate methyldopa to intermediates which are bound irreversibly to cellular proteins."1.26Methyldopa binding to cells in culture. ( Dybing, E, 1977)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19907 (58.33)18.7374
1990's2 (16.67)18.2507
2000's2 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Komoto, K1
Nomoto, T1
El Muttaqien, S1
Takemoto, H1
Matsui, M1
Miura, Y1
Nishiyama, N1
Nevo, I1
Sagi-Assif, O1
Edry Botzer, L1
Amar, D1
Maman, S1
Kariv, N1
Leider-Trejo, LE1
Savelyeva, L1
Schwab, M1
Yron, I1
Witz, IP1
Erez, N1
Milyavsky, M1
Eilam, R1
Shats, I1
Goldfinger, N1
Rotter, V1
Hammersley, PA1
Sephton, RG2
De Abrew, S2
Hodgson, GS1
Mathias, CJ1
Wang, S1
Lee, RJ1
Waters, DJ1
Low, PS1
Green, MA1
Kemp, JD1
Dybing, E1
Hoffer, PB1
Samuel, A1
Bushberg, JT1
Thakur, M1
Koizumi, M1
Endo, K1
Kunimatsu, M1
Sakahara, H1
Nakashima, T1
Kawamura, Y1
Watanabe, Y1
Saga, T1
Konishi, J1
Yamamuro, T1
Brockman, RW1

Reviews

2 reviews available for deferoxamine and Experimental Neoplasms

ArticleYear
Iron deprivation and cancer: a view beginning with studies of monoclonal antibodies against the transferrin receptor.
    Histology and histopathology, 1997, Volume: 12, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Deferoxamine; Gallium; Humans; Iron; Mice; N

1997
Biochemical aspects of drug combinations.
    Cancer chemotherapy reports. Part 2, 1974, Volume: 4, Issue:1

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Bleomycin; Camptothecin; Cell Division; Cytarabin

1974

Other Studies

10 other studies available for deferoxamine and Experimental Neoplasms

ArticleYear
Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine.
    Cancer science, 2021, Volume: 112, Issue:1

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Drug Carriers; Iron Chelatin

2021
Generation and characterization of novel local and metastatic human neuroblastoma variants.
    Neoplasia (New York, N.Y.), 2008, Volume: 10, Issue:8

    Topics: Adrenal Gland Neoplasms; Animals; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Disease Models

2008
Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.
    Cancer research, 2003, Dec-15, Volume: 63, Issue:24

    Topics: Animals; Cell Division; Cell Hypoxia; Deferoxamine; DNA-Binding Proteins; HCT116 Cells; Humans; Hypo

2003
Relative tumour enhancement of 67Ga uptake by desferrioxamine.
    European journal of nuclear medicine, 1984, Volume: 9, Issue:10

    Topics: Animals; Deferoxamine; Gallium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantat

1984
Mechanisms of distribution of gallium 67 in mouse tumour hosts.
    The British journal of radiology, 1982, Volume: 55, Issue:650

    Topics: Animals; Deferoxamine; Gallium Radioisotopes; Iron Radioisotopes; Kinetics; Male; Mice; Mice, Inbred

1982
Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:6

    Topics: Animals; Carrier Proteins; Deferoxamine; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Ma

1996
Methyldopa binding to cells in culture.
    Acta pharmacologica et toxicologica, 1977, Volume: 40, Issue:1

    Topics: Acetaminophen; Allopurinol; Animals; Ascorbic Acid; Carcinoma, Hepatocellular; Cells, Cultured; Defe

1977
Desferoxamine mesylate (Desferal): a contrast-enhancing agent for gallium-37 imaging.
    Radiology, 1979, Volume: 131, Issue:3

    Topics: Abscess; Animals; Deferoxamine; Drug Interactions; Gallium Radioisotopes; Image Enhancement; Melanom

1979
Effects of desferrioxamine on 67Ga distributions in tumor-bearing mice.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1979, Volume: 161, Issue:3

    Topics: Animals; Binding Sites; Deferoxamine; Gallium Radioisotopes; Iron Radioisotopes; Lymphoma; Male; Mic

1979
67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
    Cancer research, 1988, Mar-01, Volume: 48, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Deferoxamine; Drug Stability; Gallium Radioisotopes; Mice; Neoplasm

1988